27
FEB
Reports
Q4, 2023 earnings report expected
SUPN
Supernus Pharmaceuticals Inc
32.67
32.67
(0%)
EPS
$0.405
Estimated Sales
$156.45M
Market Cap
$1.47B
SUPN
1.52 (4.88%)
32.70
32.85
@MarketUpdates
United Kingdom
27
FEB
Reports
Q4, 2023 earnings report expected
SUPN
Supernus Pharmaceuticals Inc
32.67
32.67
(0%)
EPS
$0.405
Estimated Sales
$156.45M
Market Cap
$1.47B
1 Mentioned
SUPN
Supernus Pharmaceuticals Inc